June 1, 2020 / 11:22 AM / a month ago

BRIEF-Altimmune Launches Trial Of T-COVIDTM For Patients With Early Covid-19

June 1 (Reuters) - Altimmune Inc:

* ALTIMMUNE LAUNCHES CLINICAL TRIAL OF T-COVIDTM, AN INVESTIGATIONAL INTRANASAL IMMUNE MODULATOR FOR THE TREATMENT OF PATIENTS WITH EARLY COVID-19

* ALTIMMUNE INC - PLANNED PHASE 1/2 OUTPATIENT CLINICAL TRIAL WILL FOCUS ON PATIENTS WITH EARLY SARS-COV-2 INFECTION

* ALTIMMUNE INC - PLACEBO-CONTROLLED TRIAL EXPECTED TO COMMENCE IN JUNE WITH DATA READOUT EXPECTED IN Q4 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below